Clik here to view.
NCCNガイドラインでオプチューンが初発膠芽腫の標準的治療の選択肢として推奨される
ジャージー島セントへリア （ビジネスワイヤ） — ノボキュア社（NASDAQ: NVCR）は本日、全米総合がん情報ネットワーク（NCCN）が中枢神経系がんの腫瘍診療ガイドライン（NCCNガイドライン）で、オプチューンを初発膠芽腫（GBM）の標準的治療の選択肢として推奨したと発表しました。...
View ArticleClik here to view.
昆泰与DaVita临床研究宣布缔结战略联盟
北卡罗莱纳州研究三角园区和明尼阿波利斯 (美国商业资讯) — 世界最大的产品开发和整合医疗保健服务提供商昆泰和肾脏医护领域的领先者DaVita HealthCare Partners Inc.的全资子公司DaVita临床研究(DaVita Clinical...
View ArticleClik here to view.
Clik here to view.
Acucela Announces Official Name of Acucela Japan as Kubota Pharmaceutical...
SEATTLE Acucela Inc. (Tokyo: 4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
Award-winning Journalist David O’Shea Joins This Year’s Experts at the 2016...
MADISON, Wis. The largest international conference on DNA analysis for human identification, the 27th International Symposium on Human Identification (ISHI) will feature presentations from leading...
View ArticleClik here to view.
Phase I Clinical Trials Underway for First MERS Treatment
SIOUX FALLS, S.D. SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical development company, announced today that Phase I Clinical Trials are underway for its human antibody treatment...
View ArticleClik here to view.
CANbridge Signs Agreement with Boehringer Ingelheim to Manufacture Inhibitory...
SHANGHAI Boehringer Ingelheim and CANbridge Life Sciences announced that both parties have signed an agreement for the manufacture of CAN-017, an ErbB3 (HER3) inhibitory antibody to treat esophageal...
View ArticleClik here to view.
Promega Maxwell® RSC Advances High Quality Sample Prep for Food Testing
MADISON, Wis. The launch of the Maxwell® RSC PureFood GMO* and Authentication Kit for food testing delivers automated high quality sample prep for food testing labs. The Maxwell RSC PureFood GMO and...
View ArticleClik here to view.
DCAT Launches Networking Event in Barcelona to Serve Expanding Global Membership
ROBBINSVILLE, N.J. With over 40 percent of its new member companies headquartered outside North America, the Drug, Chemical & Associated Technologies Association (DCAT) is introducing a special...
View ArticleClik here to view.
Promega 2016 Corporate Responsibility Report Highlights Initiatives...
MADISON, Wis. The latest publication of the Promega Corporate Responsibility Report focuses on the organization’s thoughtful growth through expansion of energy-efficient facilities, advances in...
View ArticleClik here to view.
DCAT在巴塞罗那为不断壮大的全球会员群体举办交流活动
新泽西州罗宾斯维尔 (美国商业资讯)–药品、化学品与相关技术协会(DCAT)将于2016年10月5日（周三）晚间6:00到8:30在西班牙巴塞罗那Casa Llotja de Mar举办一场别开生面的交流活动。该协会超过40%的新企业会员都位于北美以外地区。交流会DCAT After The Show将在世界制药原料展览会(CPhI...
View ArticleClik here to view.
DCAT、世界で拡大する会員に貢献するための交流イベントをバルセロナで創始
米ニュージャージー州ロビンズビル （ビジネスワイヤ） — 新規会員企業の40パーセント以上が本社を北米以外に置いているため、医薬品・化学製品・関連技術協会（DCAT）は、スペイン・バルセロナのCasa Llotja de...
View ArticleClik here to view.
ピラマル・エンタープライゼズが高活性原薬（HPAPI）の米国CDMOアッシュ・スティーブンスを買収する契約を締結
印ムンバイ （ビジネスワイヤ） — ピラマル・エンタープライゼズ・リミテッド (PEL、NSE: PEL、BSE:...
View ArticleClik here to view.
Daiichi Sankyo Selects Veeva Vault to Streamline Submissions, eTMF, and...
PLEASANTON, Calif. & TOKYO Veeva Systems (NYSE:VEEV) today announced that Daiichi Sankyo Company, Limited (hereinafter, Daiichi Sankyo) based in Japan, selected Veeva Vault eTMF, Veeva Vault...
View ArticleClik here to view.
SAB Biotherapeutics Announces Contract with BARDA to Advance First MERS...
SIOUX FALLS, S.D. SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical development company, announced today that it has been awarded a contract for up to $5.3 million by the...
View ArticleClik here to view.
武田薬品: 医薬品アクセス（Access to Medicines）に関する新たな取り組みについて
大阪 （ビジネスワイヤ） — 当社は、このたび、アンメットメディカルニーズの高い患者さんを対象に、生命を救う可能性のある当社の革新的な医薬品に対するアクセスを改善することを目的として、医薬品アクセス（Access to...
View ArticleClik here to view.
Takeda Announces Bold, New Access to Medicines Strategy
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced the launch of a bold, new Access to Medicines (AtM) strategy, aimed at increasing access to its innovative and...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Launches Nitroglycerin Sublingual Tablets USP in the...
HYDERABAD, India & PRINCETON, NJ Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and...
View ArticleClik here to view.
OvaScience’s AUGMENT Treatment Commercially Available in Japan Through...
WALTHAM, Mass. OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that it has finalized its...
View ArticleClik here to view.
武田发布宏伟的全新药品获取战略
日本大阪 (美国商业资讯) — 武田药品工业株式会社(TOKYO:4502)今天宣布启动一项宏伟的全新药品获取(Access to Medicines, AtM)战略，旨在使面临部分最紧迫的未获满足医疗需求的患者增加获取有望挽救生命的武田创新药品。数十年来，该公司依据地区性的需求，已在世界许多地方提供产品、经费和获取。新的AtM战略以此为基础，专注于面临最紧迫的未获满足需求的地区和治疗领域。...
View Article